InsiderTrades

Form 4 for ORIC Oric Pharmaceuticals, Inc.

Accepted 2021-11-16 00:00:00 ET · period of report 2021-11-12 · accession 0000899243-21-044836 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2021-11-16 2021-11-16 ORIC COLUMN GROUP II, LP 10% J - Other $0.00 +173.5K 287.7K +152% $0
DI 2021-11-16 2021-11-12 ORIC COLUMN GROUP II, LP 10% M - OptEx $16.00 +16.6K 16.6K New +$266.0K
D 2021-11-16 2021-11-16 ORIC COLUMN GROUP II, LP 10% J - Other $0.00 -1.20M 3.57M -25% $0
DI 2021-11-16 2021-11-12 ORIC COLUMN GROUP II, LP 10% M - OptEx $0.00 -16.6K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-16 J A 86,716 $0.00 103,341 I See Footnote — — (F11) These securities are directly held by TCG LLC. The managing members of TCG LLC are the TCG II GP Managing Partners and Timothy Kutzkey (collectively, the "TCG LLC Managing Partners"). The TCG LLC Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG LLC and each of the TCG LLC Managing Partners disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
2 Common Common Stock 2021-11-16 J A 74 $0.00 74 I — —
3 Common Common Stock 2021-11-12 M A 16,625 $16.00 16,625 I See Footnote — — (F1) These securities are directly held by Peter Svennilson. Peter Svennilson is a former member of the Issuer's board of directors and previously filed his own Section 16 reports reporting his holdings.
4 Common Common Stock 2021-11-16 J A 86,716 $0.00 86,716 I See Footnote — — (F1) These securities are directly held by Peter Svennilson. Peter Svennilson is a former member of the Issuer's board of directors and previously filed his own Section 16 reports reporting his holdings.
5 Common Common Stock 2021-11-16 J D 287,702 $0.00 0 I See Footnote — — (F8) These securities are directly held by David Goeddel.
6 Common Common Stock 2021-11-16 J A 287,702 $0.00 287,702 I See Footnote — — (F5) The securities are directly held by TCG II GP. The TCG II GP Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG II GP and each individual TCG II GP Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
7 Common Common Stock 2021-11-16 J D 1,200,000 $0.00 3,568,181 D See Footnote — — (F3) The securities are directly held by TCG II LP, and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson (collectively, the "TCG II GP Managing Partners"). The TCG II GP Managing Partners may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual TCG II GP Managing Partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares. (F5) The securities are directly held by TCG II GP. The TCG II GP Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG II GP and each individual TCG II GP Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
8 Derivative Stock Option (right to buy) 2021-11-12 M D 16,625 $0.00 0 I See Footnote $16.00 · — to 2031-06-15 16,625 Common Stock (F13) The option was granted to Peter Svennilson for his service as a member of the Issuer's board of directors. (F1) These securities are directly held by Peter Svennilson. Peter Svennilson is a former member of the Issuer's board of directors and previously filed his own Section 16 reports reporting his holdings. (F12) As of the transaction date, 16,625 of the shares subject to this option have vested.